Home > Products > API > Sitagliptin
Sitagliptin
  • SitagliptinSitagliptin

Sitagliptin

Product Name: Sitagliptin
Formulae hypotheticae: C16H15F6N5O
M. Pondus: 407.31
CAS Subcriptio Number: 486460-32-6

Model:CAS NO:486460-32-6

Mitte Inquisitionem

depictio producti

Sitagliptin

Product nomen:Sitagliptin 486460-32-6
CAS No:486460-32-6
Specification: in domo

Nomen Sitagliptin
Synonyma (3R) -3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4- (2,4,5-trifluorophenyl)butan-1-unum;Sitagliptin;(3R)-3- AMino-1-[3-(trifluoroMethyl)-5,6,7,8-tetrahydro-1,2,4-riazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5 -rifluorophenyl)butan-1-unum(R)-3-amino-1-(3-(triflChemic albookuoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-unus ;Sitagliptin(3R)-3-Amino-1-[3-(trifluoro methyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one ; Sitagliptinbase, Sitagliptin-D4; Sitagliptin-D4HCL
copyRight
M. Structure CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C16H15F6N5O
M. Pondus 407.31
CAS Subcriptio Number 486460-32-6


Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum




Hot Tags: Sitagliptin, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept